retatrutide side effects clinical trial results 📈 PHASE 3 RESULTS: BY THE NUMBERS Let's break down what the trials actually showed: SURMOUNT-1 (68 weeks): • Average weight loss: 24% of body weight • Participants The Effect of Retatrutide on

PT-141 in the Context of Wellness Trends The growing popularity of peptide therapies like PT-141 reflects a broader shift toward individualized wellness and longevity solutions

Increased physical activity can help preserve muscle while reducing body fat, which may result in smaller clothing sizes even when scale weight changes slowly

doi: 10.2337/db18-0155 Wei R, Gu L, Yang J, et al

Long-acting agents seem to have a lower incidence of gastrointestinal adverse effects (166), likely due to tachyphylaxis in gastric emptying with sustained GLP-1R stimulation

Zhang Y, Rahematpura S, Ragnini KH, Moreno A, Stecyk KS, Kahng MW, Milliken BT, Hayes MR, Doyle RP, Schmidt HD